BlackRock’s Cardlytics CDLX Stock Holding History

BlackRock’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.04M	Buy	99,063 +2,441	+3%	+$23.8K	﹤0.01%	4336
2025 Q4	$1.11M	Sell	96,622 -534	-0.5%	-$8.25K	﹤0.01%	4282
2025 Q3	$2.36M	Sell	97,156 -13,339	-12%	-$222K	﹤0.01%	4044
2025 Q2	$1.82M	Sell	110,495 -204,173	-65%	-$3.53M	﹤0.01%	4088
2025 Q1	$5.73M	Sell	314,668 -8,257	-3%	-$236K	﹤0.01%	3596
2024 Q4	$12M	Buy	322,925 +9,186	+3%	+$351K	﹤0.01%	3335
2024 Q3	$10M	Sell	313,739 -1,437	-0.5%	-$79.8K	﹤0.01%	3405
2024 Q2	$25.9M	Buy	315,176 +28,100	+10%	+$3.04M	﹤0.01%	2822
2024 Q1	$41.6M	Sell	287,076 -4,127	-1%	-$348K	﹤0.01%	2546
2023 Q4	$26.8M	Buy	291,203 +26,172	+10%	+$2.66M	﹤0.01%	2841
2023 Q3	$43.7M	Sell	265,031 -20,620	-7%	-$2.68M	﹤0.01%	2474
2023 Q2	$18.1M	Buy	285,651 +26,937	+10%	+$1.63M	﹤0.01%	3104
2023 Q1	$8.78M	Sell	258,714 -13,735	-5%	-$717K	﹤0.01%	3382
2022 Q4	$15.7M	Buy	272,449 +13,239	+5%	+$818K	﹤0.01%	3161
2022 Q3	$24.4M	Sell	259,210 -3,115	-1%	-$443K	﹤0.01%	2926
2022 Q2	$58.5M	Buy	262,325 +25,215	+11%	+$8.44M	﹤0.01%	2379
2022 Q1	$130M	Sell	237,110 -2,351	-1%	-$1.42M	﹤0.01%	1958
2021 Q4	$158M	Sell	239,461 -7,498	-3%	-$5.73M	﹤0.01%	1902
2021 Q3	$207M	Sell	246,959 -4,171	-2%	-$4.23M	0.01%	1689
2021 Q2	$319M	Buy	251,130 +11,184	+5%	+$12.6M	0.01%	1426
2021 Q1	$263M	Buy	239,946 +35,059	+17%	+$46.3M	0.01%	1520
2020 Q4	$293M	Buy	204,887 +8,310	+4%	+$8.86M	0.01%	1323
2020 Q3	$139M	Buy	196,577 +21,952	+13%	+$16M	0.01%	1678
2020 Q2	$122M	Buy	174,625 +55,188	+46%	+$31.9M	﹤0.01%	1721
2020 Q1	$41.8M	Buy	119,437 +2,357	+2%	+$1.67M	﹤0.01%	2170
2019 Q4	$73.6M	Buy	117,080 +11,384	+11%	+$5.57M	﹤0.01%	2131
2019 Q3	$35.4M	Buy	105,696 +15,334	+17%	+$4.92M	﹤0.01%	2494
2019 Q2	$23.5M	Buy	90,362 +43,822	+94%	+$8.78M	﹤0.01%	2763
2019 Q1	$7.7M	Buy	46,540 +4,268	+10%	+$694K	﹤0.01%	3237
2018 Q4	$4.58M	Buy	42,272 +161	+0.4%	+$27.1K	﹤0.01%	3416
2018 Q3	$10.5M	Buy	42,111 +6,821	+19%	+$1.47M	﹤0.01%	3212
2018 Q2	$7.68M	Buy	35,290 +11,906	+51%	+$2.2M	﹤0.01%	3355
2018 Q1	$3.42M	Buy	+23,384	New	+$3.96M	﹤0.01%	3536

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return

WPM

Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BlackRock's CDLX Position: Q1 2026 in Review

BlackRock increased its Cardlytics (CDLX) stake by 2.5% in Q1 2026, buying an estimated $23.8K and bringing the position to 99,063 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #4336.

BlackRock first reported a position in CDLX in Q1 2018 and has held it in 33 quarters since. The position peaked at $319M in Q2 2021. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

BlackRock held 99,063 shares of Cardlytics worth $1.04M as of Q1 2026.
BlackRock bought 2,441 Cardlytics shares in Q1 2026, an estimated $23.8K.
Cardlytics made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #4336 holding.
BlackRock first reported a position in Cardlytics in Q1 2018 and has held it in 33 quarters since.
BlackRock's Cardlytics position peaked at $319M in Q2 2021.
58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.